Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

HAHAE
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in HAEMONETICS CORP MASS

NORTHERN TRUST CORP holds 631,542 shares of HAE (HAEMONETICS CORP MASS), worth $47.4M as of 2026-Q2. The position was increased (+9.0% shares). HAE represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$47.4M

Current Shares

631,542

Total Value Change

+$390,533

Total Shares Change

+47,129

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
631,542
+9.0%
$47.4M0.0%$75.00
32
2026-Q1
Increased
579,306
+0.3%
$32.6M0.0%$65.63
29
2025-Q4
Decreased
577,728
-4.1%
$46.3M0.0%$80.98
0
2025-Q3
Decreased
602,378
-5.2%
$29.4M0.0%$48.12
0
2025-Q2
Decreased
635,410
-2.5%
$47.4M0.0%$73.80
0
2025-Q1
Decreased
651,418
-4.0%
$41.4M0.0%$63.19
0
2024-Q4
Increased
678,261
+16.1%
$53M0.0%$76.60
34
2024-Q3
Decreased
584,413
-0.2%
$47M0.0%$79.80
0

Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used